Drug Addiction

Drug Addiction, Dysregulation of Reward, and Allostasis

Koob, G. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00195-0 · Cited by 2,953 · see citing works

Drug Addiction and Its Underlying Neurobiological Basis: Neuroimaging Evidence for the Involvement of the Frontal Cortex

Goldstein, R. Z., & Volkow, N. D. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.10.1642 · Cited by 2,667 · see citing works

Drug Dependence, a Chronic Medical Illness

McLellan, A. T., Lewis, D. C., O'Brien, C. P., & Kleber, H. D. (2000) · JAMA · doi:10.1001/jama.284.13.1689 · Cited by 2,622 · see citing works

Drug abuse: hedonic homeostatic dysregulation

Koob, G. F., & Moal, M. L. (1997) · Science · doi:10.1126/science.278.5335.52 · Cited by 2,535 · see citing works

Molecular basis of long-term plasticity underlying addiction

Nestler, E. J. (2001) · Nature reviews. Neuroscience · doi:10.1038/35053570 · Cited by 1,857 · see citing works

Addiction

Robinson, T. E., & Berridge, K. C. (2003) · Annual Review of Psychology · doi:10.1146/annurev.psych.54.101601.145237 · Cited by 1,509 · see citing works

Incentive-sensitization and addiction

Robinson, T. E., & Berridge, K. C. (2001) · Addiction · doi:10.1046/j.1360-0443.2001.9611038.x · Cited by 1,435 · see citing works

Molecular and Cellular Basis of Addiction

Nestler, E. J., & Aghajanian, G. K. (1997) · Science · doi:10.1126/science.278.5335.58 · Cited by 1,315 · see citing works

Addiction and the brain: The neurobiology of compulsion and its persistence

Hyman, S. E., & Malenka, R. C. (2001) · Nature reviews. Neuroscience · doi:10.1038/35094560 · Cited by 1,297 · see citing works

Endocannabinoid Signaling in the Brain

Wilson, R. I., & Nicoll, R. A. (2002) · Science · doi:10.1126/science.1063545 · Cited by 1,260 · see citing works

Addiction, Dopamine, and the Molecular Mechanisms of Memory

Berke, J. D., & Hyman, S. E. (2000) · Neuron · doi:10.1016/s0896-6273(00)81056-9 · Cited by 1,167 · see citing works

Drugs of Abuse and Stress Trigger a Common Synaptic Adaptation in Dopamine Neurons

Saal, D., Dong, Y., Bonci, A., & Malenka, R. C. (2003) · Neuron · doi:10.1016/s0896-6273(03)00021-7 · Cited by 1,147 · see citing works

The dopamine hypothesis of reward: past and current status

Spanagel, R., & Weiss, F. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01447-2 · Cited by 967 · see citing works

Neurobiology of relapse to heroin and cocaine seeking: a review

Shalev, U., Grimm, J. W., & Shaham, Y. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.1.1 · Cited by 880 · see citing works

Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: Historical cohort study

Zammit, S., Allebeck, P., Andreasson, S., Lundberg, I., & Lewis, G. (2002) · BMJ · doi:10.1136/bmj.325.7374.1199 · Cited by 871 · see citing works

Cognitive Functioning of Long-term Heavy Cannabis Users Seeking Treatment

Solowij, N. (2002) · JAMA · doi:10.1001/jama.287.9.1123 · Cited by 798 · see citing works

Understanding polydrug use: review of heroin and cocaine co‐use

Leri, F., Bruneau, J., & Stewart, J. (2002) · Addiction · doi:10.1046/j.1360-0443.2003.00236.x · Cited by 791 · see citing works

Salvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist

Roth, B. L., Baner, K., Westkaemper, R., Siebert, D., Rice, K. C., Steinberg, S., Ernsberger, P., & Rothman, R. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182234399 · Cited by 784 · see citing works

Adverse effects of cannabis

Hall, W., & Solowij, N. (1998) · The Lancet · doi:10.1016/s0140-6736(98)05021-1 · Cited by 778 · see citing works

Psychomotor stimulant addiction: a neural systems perspective

Everitt, B. J., & Wolf, M. E. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03312.2002 · Cited by 700 · see citing works

Disruption of CREB function in brain leads to neurodegeneration

Mantamadiotis, T., Lemberger, T., Bleckmann, S. C., Kern, H., Kretz, O., Villalba, A. M., Tronche, F., Kellendonk, C., Gau, D., Kapfhammer, J., et al. (2002) · Nature Genetics · doi:10.1038/ng882 · Cited by 684 · see citing works

ΔFosB: A sustained molecular switch for addiction

Nestler, E. J., Barrot, M., & Self, D. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191352698 · Cited by 640 · see citing works

A Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid Dependence

Johnson, R. E., Chutuape, M. A., Strain, E. C., Walsh, S. L., Stitzer, M. L., & Bigelow, G. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011023431802 · Cited by 623 · see citing works

Exploring the opioid system by gene knockout

Kieffer, B. L., & Gavériaux-Ruff, C. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00008-4 · Cited by 620 · see citing works

Naltrexone in the Treatment of Alcohol Dependence

Krystal, J. H., Cramer, J. A., Krol, W. F., Kirk, G. F., & Rosenheck, R. A. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011127 · Cited by 618 · see citing works

Dose-related neurocognitive effects of marijuana use

Bolla, K. I., Brown, K., Eldreth, D. A., Tate, K., & Cadet, J. L. (2002) · Neurology · doi:10.1212/01.wnl.0000031422.66442.49 · Cited by 609 · see citing works

Decreased gray matter concentration in the insular, orbitofrontal, cingulate, and temporal cortices of cocaine patients

Franklin, T. R., Acton, P. D., Maldjian, J. A., Gray, J. D., Croft, J. R., Dackis, C. A., O’Brien, C. P., & Childress, A. R. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01269-0 · Cited by 600 · see citing works

Office-Based Treatment of Opiate Addiction with a Sublingual-Tablet Formulation of Buprenorphine and Naloxone

Fudala, P. J., Bridge, T. P., Herbert, S., Williford, W. O., Chiang, C. N., Jones, K., Collins, J., Raisch, D., Casadonte, P., Goldsmith, R. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022164 · Cited by 577 · see citing works

D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes

Noble, E. P. (2003) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.10005 · Cited by 501 · see citing works

Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates

Rasmussen, K., Beitner‐Johnson, D., Krystal, J. H., Aghajanian, G. K., & Nestler, E. J. (1990) · Journal of Neuroscience · doi:10.1523/jneurosci.10-07-02308.1990 · Cited by 439 · see citing works

Cellular and synaptic mechanisms of nicotine addiction

Mansvelder, H. D., & McGehee, D. S. (2002) · Journal of Neurobiology · doi:10.1002/neu.10148 · Cited by 438 · see citing works

Molecular Neurobiology of Addiction

Nestler, E. J. (2001) · American Journal on Addictions · doi:10.1080/105504901750532094 · Cited by 412 · see citing works

Evidence for long-term neurotoxicity associated with methamphetamine abuse

Ernst, T., Chang, L., Leonido–Yee, M., & Speck, O. (2000) · Neurology · doi:10.1212/wnl.54.6.1344 · Cited by 373 · see citing works

Pharmacotherapy of addictions

Kreek, M. J., LaForge, K. S., & Butelman, E. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd897 · Cited by 371 · see citing works

Localization and Mechanisms of Action of Cannabinoid Receptors at the Glutamatergic Synapses of the Mouse Nucleus Accumbens

Robbe, D., Alonso, G., Duchamp, F., Bockaert, J., & Manzoni, O. J. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-01-00109.2001 · Cited by 367 · see citing works

A missense mutation in human fatty acid amide hydrolase associated with problem drug use

Sipe, J. C., Chiang, K. P., Gerber, A. L., Beutler, E., & Cravatt, B. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082235799 · Cited by 354 · see citing works

Regulation of Opioid Receptor Trafficking and Morphine Tolerance by Receptor Oligomerization

He, L., Fong, J. C., von Zastrow, M., & Whistler, J. L. (2002) · Cell · doi:10.1016/s0092-8674(02)00613-x · Cited by 340 · see citing works

Behavioral Neurobiology of Alcohol Addiction: Recent Advances and Challenges

Weiss, F., & Porrino, L. J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03332.2002 · Cited by 327 · see citing works

Drug addiction as dopamine-dependent associative learning disorder

Chiara, G. D. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00372-6 · Cited by 317 · see citing works

Management of Cocaine Abuse and Dependence

Mendelson, J. H., & Mello, N. K. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604113341507 · Cited by 291 · see citing works

Elevated levels of GluR1 in the midbrain: a trigger for sensitization to drugs of abuse?

Carlezon, W. A., & Nestler, E. J. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02289-0 · Cited by 281 · see citing works

Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons.

Sklair‐Tavron, L., Shi, W. X., Lane, S. B., Harris, H. W., Bunney, B. S., & Nestler, E. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.11202 · Cited by 278 · see citing works

Neural Systems Underlying Opiate Addiction

De Vries, T. J., & Shippenberg, T. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03321.2002 · Cited by 270 · see citing works

Patients with Alcohol Problems

O’Connor, P. G., & Schottenfeld, R. S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802263380907 · Cited by 267 · see citing works

Neuronal Systems Underlying Behaviors Related to Nicotine Addiction: Neural Circuits and Molecular Genetics

Picciotto, M. R., & Corrigall, W. A. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03338.2002 · Cited by 261 · see citing works

Drug therapy for alcohol dependence

Swift, R. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905133401907 · Cited by 255 · see citing works

Human Pharmacology of 3,4-Methylenedioxymeth-amphetamine ("Ecstasy"): Psychomotor Performance and Subjective Effects

Camí, J., Farré, M., Mas, M., Roset, P. N., Poudevida, S., Mas, A., San, L., & de la Torre, R. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200008000-00010 · Cited by 234 · see citing works

Duplications and Defects in the CYP2A6 Gene: Identification, Genotyping, and In Vivo Effects on Smoking

Rao, Y., Hoffmann, E. B., Zia, M., Bodin, L., Zeman, M., Sellers, E. M., & Tyndale, R. F. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.4.747 · Cited by 231 · see citing works

Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans

Harris, D. S., Baggott, M., Mendelson, J. H., Mendelson, J. E., & Jones, R. T. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1131-1 · Cited by 229 · see citing works

Marijuana Abstinence Effects in Marijuana Smokers Maintained in Their Home Environment

Budney, A. J., Hughes, J. R., Moore, B. A., & Novy, P. L. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.10.917 · Cited by 223 · see citing works

Attenuation of Nicotine-Induced Antinociception, Rewarding Effects, and Dependence in μ-Opioid Receptor Knock-Out Mice

Berrendero, F., Kieffer, B. L., & Maldonado, R. J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-24-10935.2002 · Cited by 222 · see citing works

Genes and addiction

Nestler, E. J. (2000) · Nature Genetics · doi:10.1038/81570 · Cited by 208 · see citing works

A Genome-Wide Search for Genes That Relate to a Low Level of Response to Alcohol

Schuckit, M. A., Edenberg, H. J., Kalmijn, J. A., Wetherill, L. F., Smith, T. L., Reich, T., Bierut, L. J., Goate, A., & Foroud, T. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02217.x · Cited by 208 · see citing works

Cannabinoid Addiction: Behavioral Models and Neural Correlates

Maldonado, R. J., & de Fonseca, F. R. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03326.2002 · Cited by 205 · see citing works

Genetic Contributions to Addiction

Crabbe, J. C. (2002) · Annual Review of Psychology · doi:10.1146/annurev.psych.53.100901.135142 · Cited by 203 · see citing works

Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats

Fattore, L., Cossu, G., Martellotta, C., & Fratta, W. (2001) · Psychopharmacology · doi:10.1007/s002130100734 · Cited by 187 · see citing works

Drugs of abuse: behavioural principles, methods and terms

Stolerman, I. P. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90059-f · Cited by 182 · see citing works

Drug abuse potential evaluation in animals

Balster, R. L. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01747.x · Cited by 181 · see citing works

Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis

Farré, M., Mas, A., Torrens, M., Moreno, V. R., & Camı́, J. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00171-5 · Cited by 180 · see citing works

A Functional Neuropeptide Y Leu7Pro Polymorphism Associated With Alcohol Dependence in a Large Population Sample From the United States

Lappalainen, J., Kranzler, H. R., Malison, R. T., Price, L. H., van Dyck, C. H., Rosenheck, R. A., Cramer, J. A., Southwick, S. M., Charney, D. S., Krystal, J. H., et al. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.9.825 · Cited by 176 · see citing works

Substance Misuse in Patients with Schizophrenia

Kavanagh, D. J., McGrath, J. J., Saunders, J. B., Dore, G. M., & Clark, D. (2002) · Drugs · doi:10.2165/00003495-200262050-00003 · Cited by 156 · see citing works

Individual Differences in the Biphasic Effects of Ethanol

Holdstock, L., & de Wit, H. (1998) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1998.tb05897.x · Cited by 153 · see citing works

CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats

Navarro, M., Chowen, J., Carrera, M. R. A., del Arco, I., Villanúa, M. A., Martin, Y., Roberts, A. J., Koob, G. F., & de Fonseca, F. R. (1998) · NeuroReport · doi:10.1097/00001756-199810260-00012 · Cited by 152 · see citing works

Office-Based Treatment of Opioid-Dependent Patients

Fiellin, D. A., & O'Connor, P. G. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp013579 · Cited by 148 · see citing works

Cocaine’s Effects on Neuroendocrine Systems: Clinical and Preclinical Studies

Mello, N. K., & Mendelson, J. H. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00433-9 · Cited by 137 · see citing works

Study of cannabinoid dependence in animals

Maldonado, R. J. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00254-1 · Cited by 136 · see citing works

Molecular Mechanisms for Heterologous Sensitization of Adenylate Cyclase

Watts, V. J. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.1.1 · Cited by 135 · see citing works

Learning about addiction from the genome

Nestler, E. J., & Landsman, D. (2001) · Nature · doi:10.1038/35057015 · Cited by 133 · see citing works

Pharmacokinetic considerations in abuse liability evaluation

Farré, M., & Camı́, J. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01754.x · Cited by 112 · see citing works

Substance abuse vulnerability loci: converging genome scanning data

Uhl, G. R., Liu, Q., & Naiman, D. Q. (2002) · Trends in Genetics · doi:10.1016/s0168-9525(02)02719-1 · Cited by 94 · see citing works

ΔFosB: a molecular switch underlying long-term neural plasticity

Kelz, M. B., & Nestler, E. J. (2000) · Current Opinion in Neurology · doi:10.1097/00019052-200012000-00017 · Cited by 92 · see citing works

Drug Addictions

Kreek, M. J. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03557.x · Cited by 82 · see citing works

Experimental Genetic Approaches to Addiction

Laakso, A., Mohn, A. R., Gainetdinov, R. R., & Caron, M. G. (2002) · Neuron · doi:10.1016/s0896-6273(02)00972-8 · Cited by 80 · see citing works

Crack cocaine and cocaine hydrochloride. Are the differences myth or reality?

Hatsukami, D. K. (1996) · JAMA · doi:10.1001/jama.276.19.1580 · Cited by 76 · see citing works

Addiction or dependence?

Maddux, J. F., & Desmon, D. P. (2000) · Addiction · doi:10.1046/j.1360-0443.2000.9556611.x · Cited by 64 · see citing works

Novelty seeking as a predictor of treatment retention for heroin dependent cocaine users

Helmus, T. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00153-8 · Cited by 64 · see citing works

Alprazolam absorption kinetics affects abuse liability

Mumford, G. K., Evans, S. M., Fleishaker, J. C., & Griffiths, R. R. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90162-0 · Cited by 63 · see citing works

Hypercortisolism after opioid discontinuation in rapid detoxification of heroin addicts

CAMÍ, J., GILABERT, M., SAN, L., & DE LA TORRE, R. (1992) · British Journal of Addiction · doi:10.1111/j.1360-0443.1992.tb02001.x · Cited by 55 · see citing works

Inhibition of Cytochrome P450 2D6 Modifies Codeine Abuse Liability

Kathiramalainathan, K., Kaplan, H. L., Romach, M. K., Busto, U. E., Li, N.-Y., Säwe, J., Tyndale, R. F., & Sellers, E. M. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200008000-00008 · Cited by 54 · see citing works

Treatment of Heroin (Diamorphine) Addiction

Gonzalez, G. M., Oliveto, A. H., & Kosten, T. R. (2002) · Drugs · doi:10.2165/00003495-200262090-00004 · Cited by 46 · see citing works

Abuse liability of flunitrazepam among methadone-maintained patients

Farré, M., Terán, M.-T., Roset, P. N., Más, M., Torrens, M., & Camı́, J. (1998) · Psychopharmacology · doi:10.1007/s002130050793 · Cited by 42 · see citing works

Modulation of rate of onset and intensity of drug effects reduces abuse potential in healthy males

Roset, P. N., Farré, M., de la Torre, R., Más, M., Menoyo, E., Hernández, C., & Camı́, J. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00127-2 · Cited by 35 · see citing works

Distinct Molecular Basis for Differential Sensitivity of the Serotonin Type 3A Receptor to Ethanol in the Absence and Presence of Agonist

Zhang, L., Hosoi, M., Fukuzawa, M., Sun, H., Rawlings, R. R., & Weight, F. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207683200 · Cited by 27 · see citing works

Identification of the Endogenous Cannabinoid System through Integrative Pharmacological Approaches

Martin, B. R. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.790 · Cited by 25 · see citing works

Addition of a 5-HT receptor agonist to methylphenidate potentiates the reduction of [123I]FP-CIT binding to dopamine transporters in rat frontal cortex and hippocampus

Reneman, L., de Bruin, K. M., Lavalaye, J., Gunning, W. B., & Booij, J. (2001) · Synapse · doi:10.1002/1098-2396(20010301)39:3 · Cited by 16 · see citing works

Benzodiazepines and the other sedative-hypnotics

(2016) · Oxford University Press eBooks · doi:10.1093/med/9780198714750.003.0013 · Cited by 14 · see citing works

Human drug abuse liability: testing times ahead

Camı́, J. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01741.x · Cited by 6 · see citing works

Behavioral and Molecular Aspects of Alcohol Craving and Relapse

Spanagel, R. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-343-9_15 · Cited by 2 · see citing works

Behavioral and Molecular Aspects of Alcohol Craving and Relapse

Spanagel, R. (2003) · Humana Press eBooks · doi:10.1385/1-59259-343-7:295 · Cited by 1 · see citing works

2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association

Kleindorfer, D. O., Towfighi, A., Chaturvedi, S., Cockroft, K. M., Gutierrez, J., Lombardi-Hill, D., Kamel, H., Kernan, W. N., Kittner, S. J., Leira, E. C., et al. (2021) · Stroke · doi:10.1161/str.0000000000000375 · Cited by 3,237 · see citing works

Guidelines for the Primary Prevention of Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association

Meschia, J. F., Bushnell, C., Boden-Albala, B., Braun, L. T., Bravata, D. M., Chaturvedi, S., Creager, M. A., Eckel, R. H., Elkind, M. S. V., Fornage, M., et al. (2014) · Stroke · doi:10.1161/str.0000000000000046 · Cited by 2,650 · see citing works

Primary Prevention of Ischemic Stroke

Goldstein, L. B., Adams, R. J., Alberts, M. J., Appel, L. J., Brass, L. M., Bushnell, C., Culebras, A., DeGraba, T. J., Gorelick, P. B., Guyton, J. R., et al. (2006) · Stroke · doi:10.1161/01.str.0000223048.70103.f1 · Cited by 1,359 · see citing works

Guidelines for the Primary Prevention of Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

Goldstein, L. B., Bushnell, C. D., Adams, R. J., Appel, L. J., Braun, L. T., Chaturvedi, S., Creager, M. A., Culebras, A., Eckel, R. H., Hart, R. G., et al. (2011) · Stroke · doi:10.1161/str.0b013e3181fcb238 · Cited by 1,306 · see citing works

Involvement of the endocannabinoid system in drug addiction

Maldonado, R. J., Valverde, O., & Berrendero, F. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.01.008 · Cited by 584 · see citing works

Opioid dependence and addiction during opioid treatment of chronic pain

Ballantyne, J. C., & LaForge, S. K. (2007) · Pain · doi:10.1016/j.pain.2007.03.028 · Cited by 445 · see citing works

The neurocircuitry of addiction: an overview

Feltenstein, M. W., & See, R. E. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.51 · Cited by 421 · see citing works

What are the specific vs. generalized effects of drugs of abuse on neuropsychological performance?

Fernández-Serrano, M. J., Pérez-García, M., & Verdejo-García, A. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.04.008 · Cited by 387 · see citing works

Lateral hypothalamic orexin/hypocretin neurons: A role in reward-seeking and addiction

Aston‐Jones, G., Smith, R. J., Sartor, G. C., Moorman, D. E., Massi, L., Tahsili‐Fahadan, P., & Richardson, K. A. (2009) · Brain Research · doi:10.1016/j.brainres.2009.09.106 · Cited by 386 · see citing works

Diacetylmorphine versus Methadone for the Treatment of Opioid Addiction

Oviedo‐Joekes, E., Brissette, S., Marsh, D. C., Lauzon, P., Guh, D. P., Anis, A. H., & Schechter, M. T. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810635 · Cited by 371 · see citing works

The Effects of Toluene on the Central Nervous System

Filley, C. M., HALLIDAY, W. C., & Kleinschmidt‐DeMasters, B. K. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.1.1 · Cited by 364 · see citing works

Efficacy of Opioids for Chronic Pain: A Review of the Evidence

Ballantyne, J., & Shin, N. S. (2008) · The Clinical Journal of Pain · doi:10.1097/ajp.0b013e31816b2f26 · Cited by 361 · see citing works

Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of ayahuasca: a longitudinal study.

Bouso, J. C., González, D., Fondevila, S., Cutchet, M., Fernández, X., Ribeiro Barbosa, P. C., Alcázar-Córcoles, M. Á., Araújo, W. S., Barbanoj, M. J., Fábregas, J. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042421 · Cited by 313 · see citing works

γ-Hydroxybutyric Acid

Snead, O. C., & Gibson, K. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmra044047 · Cited by 311 · see citing works

Deep brain stimulation: from neurology to psychiatry?

Krack, P., Hariz, M. I., Baunez, C., Guridi, J., & Obeso, J. A. (2010) · Trends in Neurosciences · doi:10.1016/j.tins.2010.07.002 · Cited by 305 · see citing works

Cannabinoid CB1 Receptor Antagonists as Promising New Medications for Drug Dependence

Foll, B. L., & Goldberg, S. R. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.077974 · Cited by 290 · see citing works

Suboptimal Addiction Interventions for Patients Hospitalized with Injection Drug Use-Associated Infective Endocarditis

Rosenthal, E. S., Karchmer, A. W., Theisen-Toupal, J. C., Araujo-Castillo, R. V., & Rowley, C. F. (2015) · The American Journal of Medicine · doi:10.1016/j.amjmed.2015.09.024 · Cited by 282 · see citing works

Current perspectives on selective dopamine D3 receptor antagonists as pharmacotherapeutics for addictions and related disorders

Heidbreder, C., & Newman, A. H. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05149.x · Cited by 303 · see citing works

Internet Sex Addiction Treated With Naltrexone

Bostwick, J. M., & Bucci, J. A. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.2.226 · Cited by 265 · see citing works

Ketamine abuse potential and use disorder

Liu, Y., Lin, D., Wu, B., & Zhou, W. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.05.016 · Cited by 256 · see citing works

Definition of Substance and Non-substance Addiction

Zou, Z., Wang, H., d’Oleire Uquillas, F., Wang, X., Ding, J., & Chen, H. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-10-5562-1_2 · Cited by 252 · see citing works

Sleep, Anesthesiology, and the Neurobiology of Arousal State Control

Lydic, R., & Baghdoyan, H. A. (2005) · Anesthesiology · doi:10.1097/00000542-200512000-00024 · Cited by 251 · see citing works

Assessment of addiction severity among ritual users of ayahuasca.

Fábregas, J. M., González, D., Fondevila, S., Cutchet, M., Fernández, X., Barbosa, P. C. R., Alcázar-Córcoles, M. Á., Barbanoj, M. J., Riba, J., & Bouso, J. C. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.03.024 · Cited by 227 · see citing works

Multiple roles for orexin/hypocretin in addiction

Mahler, S. V., Smith, R. J., Moorman, D. E., Sartor, G. C., & Aston-Jones, G. (2012) · Progress in Brain Research · doi:10.1016/b978-0-444-59489-1.00007-0 · Cited by 215 · see citing works

Cannabis and cognitive dysfunction: Parallels with endophenotypes of schizophrenia?

Solowij, N., & Michie, P. T. (2007) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0705 · Cited by 201 · see citing works

Overcoming Barriers to Prevention, Care, and Treatment of Hepatitis C in Illicit Drug Users

Edlin, B. R., Kresina, T. F., Raymond, D., Carden, M. R., Gourevitch, M. N., Rich, J. D., Cheever, L. W., & Cargill, V. A. (2005) · Clinical Infectious Diseases · doi:10.1086/427441 · Cited by 192 · see citing works

Impact of general cognition and executive function deficits on addiction treatment outcomes: Systematic review and discussion of neurocognitive pathways

Domínguez‐Salas, S., Díaz, C., Lozano, O. M., & Verdejo‐García, A. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.09.030 · Cited by 190 · see citing works

The research domain criteria framework: The case for anterior cingulate cortex

Holroyd, C. B., & Umemoto, A. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.09.021 · Cited by 187 · see citing works

New treatments for cocaine dependence: a focused review

Karila, L., Gorelick, D. A., Weinstein, A. M., Noble, F., Benyamina, A., Coscas, S., Blecha, L., Lowenstein, W., Martinot, J., Reynaud, M., et al. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008097 · Cited by 176 · see citing works

Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics

Farré, M., de la Torre, R., Mathúna, B. Ó., Roset, P. N., Peiró, A. M., Torrens, M., Ortuño, J., Pujadas, M., & Camı́, J. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1789-7 · Cited by 165 · see citing works

Individual variation in resisting temptation: Implications for addiction

Saunders, B. T., & Robinson, T. E. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.02.008 · Cited by 165 · see citing works

A Qualitative Analysis of Online Gaming Addicts in Treatment

Beranuy, M., Carbonell, X., & Griffiths, M. D. (2012) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-012-9405-2 · Cited by 159 · see citing works

Clinical correlates of tardive dyskinesia in schizophrenia: Baseline data from the CATIE schizophrenia trial

Miller, D. D., McEvoy, J. P., Thomas, S., Caroff, S. N., Saltz, B. L., Chakos, M., Swartz, M. S., Keefe, R. S. E., Rosenheck, R. A., Stroup, T. S., et al. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.07.034 · Cited by 157 · see citing works

Clinical Pharmacokinetics of Amfetamine and Related Substances

de la Torre, R., Farr, M., Navarro, M., Pacifici, R., Zuccaro, P., & Pichini, S. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443030-00002 · Cited by 149 · see citing works

Human Pharmacology of Mephedrone in Comparison with MDMA

Papaseit, E., Pérez‐Mañá, C., Mateus, J. A., Pujadas, M., Fonseca, F., Torrens, M., Olesti, E., de la Torre, R., & Farré, M. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.75 · Cited by 149 · see citing works

Cognitive function during early abstinence from opioid dependence: a comparison to age, gender, and verbal intelligence matched controls

Rapeli, P., Kivisaari, R., Autti, T. H., Kähkönen, S., Puuskari, V., Jokela, O., & Kalska, H. (2006) · BMC Psychiatry · doi:10.1186/1471-244x-6-9 · Cited by 137 · see citing works

Update and Overview of Practical Epidemiologic Aspects of HIV/AIDS among Injection Drug Users in the United States

Santibanez, S. S., Garfein, R. S., Swartzendruber, A. L., Purcell, D. W., Paxton, L. A., & Greenberg, A. E. (2006) · Journal of Urban Health · doi:10.1007/s11524-005-9009-2 · Cited by 129 · see citing works

Structure and therapeutic uses of butyrylcholinesterase: Application in detoxification, Alzheimer's disease, and fat metabolism

Xing, S., Li, Q., Xiong, B., Chen, Y., Feng, F., Liu, W., & Sun, H. (2020) · Medicinal Research Reviews · doi:10.1002/med.21745 · Cited by 126 · see citing works

Drugs of Abuse, Dopamine, and HIV-Associated Neurocognitive Disorders/HIV-Associated Dementia

Purohit, V., Rapaka, R. S., & Shurtleff, D. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8195-z · Cited by 117 · see citing works

Gut Microbiota Analysis in Rats with Methamphetamine-Induced Conditioned Place Preference

Ning, T., Gong, X., Xie, L., & Ma, B. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01620 · Cited by 116 · see citing works

Medication Overuse Headache (MOH) is a Biobehavioural Disorder

Saper, J., Hamel, R. L., & Lake, A. (2005) · Cephalalgia · doi:10.1111/j.1468-2982.2005.00879.x · Cited by 114 · see citing works

Overview of the pharmacogenomics of cigarette smoking

Ho, M., & Tyndale, R. F. (2007) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500436 · Cited by 114 · see citing works

Full Opioid Agonists and Tramadol: Pharmacological and Clinical Considerations

Edinoff, A. N., Kaplan, L. A., Khan, S. U., Petersen, M., Sauce, E., Causey, C. D., Cornett, E. M., Imani, F., Moghaddam, O. M., Kaye, A. M., et al. (2021) · Anesthesiology and Pain Medicine · doi:10.5812/aapm.119156 · Cited by 111 · see citing works

Neural Substrates of Psychostimulant Withdrawal-Induced Anhedonia

D’Souza, M. S., & Markou, A. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_20 · Cited by 107 · see citing works

The "Ups and Downs" of Signaling Cascades in Addiction

Dorit Ron, A., & Jurd, R. (2005) · Science s STKE · doi:10.1126/stke.3092005re14 · Cited by 106 · see citing works

Psychological medicine

(2009) · Elsevier eBooks · doi:10.1016/b978-0-7020-2993-6.00027-4 · Cited by 106 · see citing works

The Human Nucleus Accumbens: Where Is It? A Stereotactic, Anatomical and Magnetic Resonance Imaging Study

Neto, L. L., Oliveira, E., Correia, F., & Gonçalves-Ferreira, A. (2008) · Neuromodulation Technology at the Neural Interface · doi:10.1111/j.1525-1403.2007.00138.x · Cited by 105 · see citing works

Prediction of relapse to frequent heroin use and the role of methadone prescription: An analysis of the Amsterdam Cohort Study among drug users

Termorshuizen, F., Krol, A., Prins, M., Geskus, R. B., van den Brink, W., & van Ameijden, E. J. C. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.01.013 · Cited by 104 · see citing works

Drug-induced Alterations in the Extracellular Signal-regulated Kinase (ERK) Signalling Pathway: Implications for Reinforcement and Reinstatement

Zhai, H., Li, Y., Wang, X., & Lü, L. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9240-3 · Cited by 91 · see citing works

GHB and synthetic cathinones: clinical effects and potential consequences

Karila, L., & Reynaud, M. (2010) · Drug Testing and Analysis · doi:10.1002/dta.210 · Cited by 89 · see citing works

Application of metabolomics to toxicology of drugs of abuse: A mini review of metabolomics approach to acute and chronic toxicity studies

Zaitsu, K., Hayashi, Y., Kusano, M., Tsuchihashi, H., & Ishii, A. (2015) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2015.10.002 · Cited by 89 · see citing works

Neural Substrates and Circuits of Drug AddictionPreprint

Feltenstein, M. W., See, R. E., & Fuchs, R. A. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a039628 · Cited by 88 · see citing works

The influence of executive functions, sensation seeking, and HIV serostatus on the risky sexual practices of substance-dependent individuals

Gonzalez, R., Vassileva, J., Bechara, A., Grbesic, S., Sworowski, L., Novak, R., Nunnally, G., & Martin, E. (2005) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617705050186 · Cited by 88 · see citing works

Metabolic profiling of urine and blood plasma in rat models of drug addiction on the basis of morphine, methamphetamine, and cocaine-induced conditioned place preference

Zaitsu, K., Miyawaki, I., Bando, K., Horie, H., Shima, N., Katagi, M., Tatsuno, M., Bamba, T., Sato, T., Ishii, A., et al. (2013) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-013-7234-1 · Cited by 85 · see citing works

Does comorbid substance use disorder impair recovery from major depression with SSRI treatment? An analysis of the STAR*D level one treatment outcomes

Davis, L. L., Wisniewski, S. R., Howland, R. H., Trivedi, M. H., Husain, M. M., D, M. F. M., McGrath, P. J., Balasubramani, G. K., Warden, D., & Rush, A. J. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.10.003 · Cited by 85 · see citing works

Drug-seeking motivation level in male rats determines offspring susceptibility or resistance to cocaine-seeking behaviour

Le, Q., Yan, B., Yu, X., Li, Y., Song, H., Zhu, H., Hou, W., Ma, D., Wu, F., Zhou, Y., et al. (2017) · Nature Communications · doi:10.1038/ncomms15527 · Cited by 84 · see citing works

Combined Neuroimaging, Neurocognitive and Psychiatric Factors to Predict Alcohol Consumption Following Treatment for Alcohol Dependence

Durazzo, T. C., Gazdzinski, S. P., Yeh, P., & Meyerhoff, D. J. (2008) · Alcohol and Alcoholism · doi:10.1093/alcalc/agn078 · Cited by 83 · see citing works

Metabolism and metabolomics of opiates: A long way of forensic implications to unravel

Dinis‐Oliveira, R. J. (2018) · Journal of Forensic and Legal Medicine · doi:10.1016/j.jflm.2018.12.005 · Cited by 82 · see citing works

Discovery of endogenous opioid systems: what it has meant for the clinician's understanding of pain and its treatment

Ballantyne, J. C., & Sullivan, M. D. (2017) · Pain · doi:10.1097/j.pain.0000000000001043 · Cited by 79 · see citing works

k Opioids as potential treatments for stimulant dependence

Prisinzano, T. E., Tidgewell, K. J., & Harding, W. W. (2005) · The AAPS Journal · doi:10.1208/aapsj070361 · Cited by 79 · see citing works

Psychostimulant Treatment of Cocaine Dependence

Mariani, J. J., & LEVIN, F. R. (2012) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2012.03.012 · Cited by 78 · see citing works

Current and Potential Pharmacological Treatment Options for Maintenance Therapy in Opioid-Dependent Individuals

Tetrault, J. M., & Fiellin, D. A. (2012) · Drugs · doi:10.2165/11597520-000000000-00000 · Cited by 76 · see citing works

Cue-induced alcohol-seeking behaviour is reduced by disrupting the reconsolidation of alcohol-related memories

von der Goltz, C., Vengeliene, V., Bilbao, A., Perreau‐Lenz, S., Pawlak, C. R., Kiefer, F., & Spanagel, R. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1544-1 · Cited by 76 · see citing works

Early Therapeutic Alliance as a Predictor of Treatment Outcome for Adolescent Cannabis Users in Outpatient Treatment

Diamond, G. S., Liddle, H. A., Wintersteen, M. B., Dennis, M. L., Godley, S. H., & Tims, F. M. (2006) · American Journal on Addictions · doi:10.1080/10550490601003664 · Cited by 76 · see citing works

Bioethics and the Brain

Glannon, W. (2006) · DigitalGeorgetown (Georgetown University Library) · doi:10.1093/acprof:oso/9780195307788.001.0001 · Cited by 75 · see citing works

The role of TNFα in the periaqueductal gray during naloxone-precipitated morphine withdrawal in rats

Hao, S., Liu, S., Zheng, X., Zheng, W., Ouyang, H., Mata, M., & Fink, D. J. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.197 · Cited by 74 · see citing works

Sensitivity to psychostimulants in mice bred for high and low stimulation to methamphetamine

Kamens, H. M., Burkhart‐Kasch, S., McKinnon, C. S., Li, N., Reed, C. L., & Phillips, T. J. (2004) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2004.00101.x · Cited by 72 · see citing works

Effects of extended-access self-administration and deprivation on breakpoints maintained by cocaine in rats

Liu, Y., Roberts, D. C. S., & Morgan, D. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2089-y · Cited by 72 · see citing works

Salvinorin A: A novel and highly selective κ-opioid receptor agonist

Yan, F., & Roth, B. L. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.07.008 · Cited by 70 · see citing works

Opioid tolerance and dependence — do they matter?

Jage, J. (2004) · European Journal of Pain · doi:10.1016/j.ejpain.2004.11.009 · Cited by 70 · see citing works

Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”): The Influence of Gender and Genetics (CYP2D6, COMT, 5-HTT)

Lozano, R. P., Farré, M., Yubero‐Lahoz, S., O’Mathúna, B., Torrens, M., Mustata, C., Pérez‐Mañá, C., Langohr, K., Cuyàs, E., Carbó, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047599 · Cited by 69 · see citing works

Genetic Determinants of Addiction to Opioids and Cocaine

Saxon, A. J., Oreskovich, M. R., & Brkanac, Z. (2005) · Harvard Review of Psychiatry · doi:10.1080/10673220500243364 · Cited by 66 · see citing works

Effect of μ-Opioid Receptor Gene Polymorphisms on Heroin-Induced Subjective Responses in a Chinese Population

Zhang, D., Shao, C., Shao, M., Yan, P., Wang, Y., Liu, Y., Liu, W., Lin, T., Xie, Y., Zhao, Y., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.012 · Cited by 63 · see citing works

Safety, pharmacokinetics, and pharmacodynamics of TV‐1380, a novel mutated butyrylcholinesterase treatment for cocaine addiction, after single and multiple intramuscular injections in healthy subjects

Cohen‐Barak, O., Wildeman, J., van de Wetering, J., Hettinga, J., Schuilenga‐Hut, P. H. L., Gross, A., Clark, S., Bassan, M., Gilgun‐Sherki, Y., Mendzelevski, B., et al. (2014) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.450 · Cited by 63 · see citing works

Challenges of opioid deprescribing and factors to be considered in the development of opioid deprescribing guidelines: a qualitative analysis

Langford, A. V., Gnjidic, D., Lin, C. C., Bero, L. A., Penm, J. H.-D., Blyth, F., & Schneider, C. R. (2020) · BMJ Quality & Safety · doi:10.1136/bmjqs-2020-010881 · Cited by 62 · see citing works

Rapid and Persistent Sensitization to the Reinforcing Effects of Cocaine

Morgan, D., Liu, Y., & Roberts, D. C. S. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300773 · Cited by 62 · see citing works

Aqueous Extract of Saffron (Crocus sativus) Increases Brain Dopamine and Glutamate Concentrations in Rats

Ettehadi, H., Mojabi, S. N., Ranjbaran, M., Shams, J., Sahraei, H., Hedayati, M., & Asefi, F. (2013) · Journal of Behavioral and Brain Science · doi:10.4236/jbbs.2013.33031 · Cited by 60 · see citing works

Neuropsychiatric Effects of Prescription Drug Abuse

Caplan, J. P., Epstein, L. A., Quinn, D. K., Stevens, J. R., & Stern, T. A. (2007) · Neuropsychology Review · doi:10.1007/s11065-007-9037-7 · Cited by 60 · see citing works

Predictors of retention in community-based methadone maintenance treatment program in Pearl River Delta, China

Yang, F., Lin, P., Li, Y., He, Q., Long, Q., Fu, X., & Luo, Y. (2013) · Harm Reduction Journal · doi:10.1186/1477-7517-10-3 · Cited by 60 · see citing works

Feeling ‘better than well’

Hall, W. (2004) · EMBO Reports · doi:10.1038/sj.embor.7400303 · Cited by 58 · see citing works

Need for Analgesics/drugs of Abuse: A Comparison Between Headache Patients and Addicts by the Leeds Dependence Questionnaire (LDQ)

Ferrari, A., Cicero, A., Bertolini, A., Leone, S., Pasciullo, G., & Sternieri, E. (2006) · Cephalalgia · doi:10.1111/j.1468-2982.2005.01020.x · Cited by 57 · see citing works

Potential role of safer injection facilities in reducing HIV and Hepatitis C infections and overdose mortality in the United States

Semaan, S., Fleming, P. J., Worrell, C. M., Stolp, H., Baack, B. N., & Miller, M. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.03.006 · Cited by 55 · see citing works

Buprenorphine for the treatment of opioid dependence

Boothby, L. A., & Doering, P. L. (2007) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp060403 · Cited by 55 · see citing works

Media campaigns for the prevention of illicit drug use in young people

Ferri, M., Allara, E., Bò, A., Gasparrini, A., & Faggiano, F. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009287.pub2 · Cited by 54 · see citing works

A DRD2 and ANKK1 haplotype is associated with nicotine dependence

Voisey, J., Swagell, C. D., Hughes, I. P., van Daal, A., Noble, E. P., Lawford, B. R., Young, R. M., & Morris, C. P. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2011.09.024 · Cited by 54 · see citing works

Sustained attention in patients receiving and abstinent following methadone maintenance treatment for opiate dependence: Performance and neuroimaging results

Prosser, J. M., London, E. D., & GALYNKER, I. I. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.04.022 · Cited by 54 · see citing works

Targeting mGluR2/3 for treatment of neurodegenerative and neuropsychiatric diseases

Li, S. H., Abd‐Elrahman, K. S., & Ferguson, S. S. G. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108275 · Cited by 52 · see citing works

COMT val158met and 5-HTTLPR Genetic Polymorphisms Moderate Executive Control in Cannabis Users

Verdejo‐García, A., Fagundo, A. B., Cuenca‐Royo, A., Rodríguez, J. C., Cuyàs, E., Langohr, K., Llopis, S. D. S., Civit, E., Farré, M., Peña‐Casanova, J., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.59 · Cited by 51 · see citing works

Binge self-administration and deprivation produces sensitization to the reinforcing effects of cocaine in rats

Morgan, D., Smith, M. A., & Roberts, D. C. S. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1992-6 · Cited by 51 · see citing works

Effects of a Rhodiola rosea L. extract on the acquisition, expression, extinction, and reinstatement of morphine-induced conditioned place preference in mice

Mattioli, L., Titomanlio, F., & Perfumi, M. C. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2686-0 · Cited by 49 · see citing works

Opioid Dependence: Rationale for and Efficacy of Existing and New Treatments

Fiellin, D. A., Friedland, G. H., & Gourevitch, M. N. (2006) · Clinical Infectious Diseases · doi:10.1086/508180 · Cited by 49 · see citing works

Iatrogenic Opioid Withdrawal in Critically Ill Patients: A Review of Assessment Tools and Management

Chiu, A. W., Contreras, S., Mehta, S., Korman, J., Perreault, M. M., Williamson, D. R., & Burry, L. D. (2017) · Annals of Pharmacotherapy · doi:10.1177/1060028017724538 · Cited by 48 · see citing works

Quantification of Dopamine in Brain Microdialysates with High-Performance Liquid Chromatography-Tandem Mass Spectrometry

Qi, D., Zhang, Q. Y., Zhou, W., Zhao, J., Zhang, B., Sha, Y., & Pang, Z. (2016) · Analytical Sciences · doi:10.2116/analsci.32.419 · Cited by 47 · see citing works

A functional glutathioneS‐transferase P1 gene polymorphism is associated with methamphetamine‐induced psychosis in Japanese population

Hashimoto, T., Hashimoto, K., Matsuzawa, D., Shimizu, E., Sekine, Y., Inada, T., Ozaki, N., Iwata, N., Harano, M., Komiyama, T., et al. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30164 · Cited by 47 · see citing works

Genetics and Genotypes in Irritable Bowel Syndrome: Implications for Diagnosis and Treatment

Park, M. I., & Camilleri, M. (2005) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2005.02.009 · Cited by 46 · see citing works

Opioids for chronic pain: Taking stock

Ballantyne, J. C. (2006) · Pain · doi:10.1016/j.pain.2006.07.005 · Cited by 46 · see citing works

Is Ricoeur's Notion of Narrative Identity Useful in Understanding Recovery in Drug Addicts?

Taïeb, O., Révah‐Levy, A., Moro, M. R., & Baubet, T. (2008) · Qualitative Health Research · doi:10.1177/1049732308318041 · Cited by 45 · see citing works

Special Section on Relapse Prevention: Relapse of Substance Use Disorder and Its Prevention Among Persons With Co-occurring Disorders

McGovern, M. P., Wrisley, B. R., & Drake, R. E. (2005) · Psychiatric Services · doi:10.1176/appi.ps.56.10.1270 · Cited by 44 · see citing works

A molecularly defined D1 medium spiny neuron subtype negatively regulates cocaine addiction

Zhao, Z., Han, X., Chen, R., Liu, Y., Bhattacherjee, A., Chen, W., & Zhang, Y. (2022) · Science Advances · doi:10.1126/sciadv.abn3552 · Cited by 44 · see citing works

The brain on opioids

Ballantyne, J. C. (2018) · Pain · doi:10.1097/j.pain.0000000000001270 · Cited by 44 · see citing works

Feature Article Molecular Mechanisms of Drug Addiction

Nestler, E. J. (2016)

Mechanisms of Drug Addiction

Munzar, P. (2003) · New England Journal of Medicine · doi:10.1056/nejm200312113492422 · Cited by 2 · see citing works

Molecular Neurobiology of Drug Addiction

Nestler, E. J. (1994) · Neuropsychopharmacology · doi:10.1038/npp.1994.37 · Cited by 100 · see citing works

The Biologic Basis of Drug and Alcohol Addiction

Katz, O. A., Katz, N. B., & Mandel, S. M. (2008) · Springer eBooks · doi:10.1007/978-0-387-71433-2_3 · Cited by 1 · see citing works

Addiction: Neurobiological Mechanism

Koob, G. F. (2009) · Elsevier eBooks · doi:10.1016/b978-008045046-9.00384-3 · Cited by 1 · see citing works